P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES by Singh, N et al.
P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS 
IN ENDOMETRIAL CANCER BIOPSIES 
 
Naveena Singh1, Anna Piskorz2, Tjalling Bosse3, Mercedes Jimenez-Linan4, Arjun Jeyarajah1, 
Ranjit Manchanda1, C Blake Gilks6, James Brenton2, Martin Köbel7 
 
1Barts Health NHS Trust, London, UK; 2University of Cambridge, Cambrige, UK; 3University of 
Leiden, Leiden, The Netherlands; 4Addenbrooke’s Hospital, Cambridge, UK; 5Vancouver 




Background and Aims 
p53 immunohistochemistry (IHC) has high specificity for TP53 mutation in 
ovarian carcinoma. Four molecular subtypes of endometrial carcinoma (EC) have 
been identified; accuracy of p53 IHC as a surrogate for TP53 mutation and 
thereby for serous-like EC is not established. We aimed to test whether p53 IHC 
predicts TP53 mutation in EC biopsies, universally and/or as part of a molecular 




200 EC biopsies were selected from 5 histopathology laboratories to include 
serous:non-serous high grade:G1-2 endometrioid EC in a 2:1:1 ratio. Local p53 
IHC results were compared to central reference results. Central p53 IHC results 
were compared to tagged-amplicon NGS TP53 sequencing results.  
 
Results  
There was 95% complete concordance between local and central p53 IHC 
results. On preliminary results, deleterious TP53 mutations were detected in 
104/170 cases (excluding cases with failed analysis (n=23) and those showing 
heterogeneous p53 IHC (n=7)). Correlation between TP53 mutation and p53 IHC 
(Table 3) shows 91% accuracy (sensitivity 90.4%; specificity 91.2%). Correlation 
between TP53 mutation and p53 IHC as part of an algorithm, ie after exclusion of 
mismatch repair defective and DNA polymerase epsilon exonuclease domain 




p53 IHC shows excellent inter-laboratory/inter-observer agreement in EC 
biopsy specimens. Our preliminary results suggest that p53 IHC is a robust 
biomarker of ‘serous-like’ EC in biopsy material, especially as part of an 
algorithm. 
 
 
 
 
 
 
